C
Christopher J. Farady
Researcher at Novartis
Publications - 18
Citations - 1164
Christopher J. Farady is an academic researcher from Novartis. The author has contributed to research in topics: Inflammasome & Biology. The author has an hindex of 7, co-authored 14 publications receiving 698 citations.
Papers
More filters
Journal ArticleDOI
GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
Lorenzo Sborgi,Sebastian Rühl,Estefania Mulvihill,Joka Pipercevic,Rosalie Heilig,Henning Stahlberg,Christopher J. Farady,Daniel J. Müller,Petr Broz,Sebastian Hiller +9 more
TL;DR: Overall, these data demonstrate that GSDMD is the direct and final executor of pyroptotic cell death.
Journal ArticleDOI
Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly.
Kaiwen W. Chen,Benjamin Demarco,Rosalie Heilig,Kateryna Shkarina,Andreas Boettcher,Christopher J. Farady,Pawel Pelczar,Petr Broz +7 more
TL;DR: It is demonstrated that during extrinsic apoptosis, caspase‐1 and caspasing‐8 cleave GSDMD to promote lytic cell death and that channel‐forming glycoprotein pannexin‐1, but not G SDMD or GSDME promotes NLRP3 inflammasome activation during casp enzyme‐8 or caspases‐9‐dependent apoptosis.
Journal ArticleDOI
Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD.
Brent H. Koehn,Asim Saha,Cameron McDonald-Hyman,Michael Loschi,Govindarajan Thangavelu,Lie Ma,Michael Zaiken,Josh Dysthe,Walker Krepps,Jamie Panthera,Keli L. Hippen,Stephen C. Jameson,Jeffrey S. Miller,Mark E. Cooper,Christopher J. Farady,Takao Iwawaki,Jenny P.-Y. Ting,Jonathan S. Serody,William J. Murphy,Geoffrey R. Hill,Geoffrey R. Hill,Peter J. Murray,Vincenzo Bronte,David H. Munn,Robert Zeiser,Bruce R. Blazar +25 more
TL;DR: It is demonstrated that conditioning regimen-induced ATP release is a primary driver of MDSC dysfunction through ATP receptor (P2x7R) engagement and NLRP3 inflammasome activation and this findings inform future clinical trials that would use M DSC to decrease alloresponses in inflammatory environments.
Journal ArticleDOI
Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition.
Carien Dekker,Henri Mattes,Michael Wright,Andreas Boettcher,Alexandra Hinniger,Nicola Hughes,Sandra Kapps-Fouthier,Jörg Eder,P. Erbel,Nikolaus Stiefl,Angela Mackay,Christopher J. Farady +11 more
TL;DR: In this paper, a crystal structure of the NLRP3 NACHT domain in complex with an inhibitor is presented, showing the inhibitor acts as an intramolecular glue, which locks the protein in an inactive conformation.
Journal ArticleDOI
Degradation of recombinant proteins by Chinese hamster ovary host cell proteases is prevented by matriptase-1 knockout
Holger Laux,Sandrine Romand,Sandro Nuciforo,Sandro Nuciforo,Christopher J. Farady,Joel Alois Rene Tapparel,Stine Buechmann-Moeller,Benjamin Sommer,Edward J. Oakeley,Ursula Bodendorf +9 more
TL;DR: The combination of novel cell line engineering tools, next‐generation sequencing screening methods, and the recently published Chinese hamster genome has enabled the development of this novel matriptase KO CHO cell line capable of improving expression yields of intact therapeutic proteins.